marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
4D Molecular Therapeutics Cash Flow 2011-2024 | FDMT
Annual Cash Flow 4D Molecular Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-75.8 M | -86.7 M | -69.1 M | -50.9 M | -36.7 M | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
4.2 M | 2.4 M | 1.52 M | 1.44 M | 1 M | - | - | - | - | - | - | - | - |
Accounts Payables |
3.52 M | 3.32 M | 4.76 M | 1.79 M | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | 47 K | 1.49 M | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow 4D Molecular Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -29.1 M | - | - | - | -27.9 M | - | -64.5 M | -43.5 M | -23.6 M | - | -47.3 M | -31.6 M | -15.4 M | - | -33.4 M | -20 M | -13.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
1.2 M | 1.2 M | 1.17 M | - | 1.1 M | 1.1 M | 1.03 M | - | 500 K | 500 K | 406 K | - | 1.13 M | 753 K | 383 K | - | 1.07 M | 703 K | 344 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.92 M | 3.43 M | 4.22 M | 3.52 M | 4.71 M | 3.49 M | - | 3.32 M | 1.48 M | 3.32 M | 2.68 M | 4.76 M | 3.71 M | 1.96 M | 1.28 M | 1.79 M | 1.79 M | 1.79 M | 1.79 M | 1.74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | 47 K | 791 K | 1.22 M | 965 K | 1.49 M | 1.49 M | 1.49 M | 1.49 M | 978 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency